In 2020, many companies tried to develop effective coronavirus vaccines, but two ended up succeeding and dominating the field: Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA). These two vaccine makers ...
(The Hill) — The Food and Drug Administration (FDA) announced Thursday the approval of both Pfizer’s and Moderna’s updated COVID-19 vaccines for the 2024-2025 respiratory viral season. The updated ...